準備中
日本臨床微生物学会を中心に薬剤耐性菌サーベイランス結果を発表しています
2023年
1. Kishita, M. et al. Increase in the frequency of community-acquired methicillin-resistant Staphylococcus aureus clones among inpatients of acute care hospitals in the Kyoto and Shiga regions, Japan. Journal of Infection and Chemotherapy 29, 458–463 (2023).
2. Iwamoto, K. et al. Meningitis caused by Chromobacterium haemolyticum suspected to be derived from a canal in Japan: a case report. J Med Case Reports 17, 171 (2023).
2022年以前
1. Kanahashi, T., Matsumura, Y., Yamamoto, M., Tanaka, M. & Nagao, M. Comparison of the Xpert Carba-R and NG-Test CARBA5 for the detection of carbapenemases in an IMP-type carbapenemase endemic region in Japan. Journal of Infection and Chemotherapy 27, 503–506 (2021).
2. Tsuchido, Y. et al. Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan. Medical Mycology 57, 997–1003 (2019).
3. Yunoki, T. et al. Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: A prospective multicenter surveillance study in Japan. Anaerobe 48, 215–223 (2017).
4. Kato, K. et al. Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan. Microb Drug Resist. 23,590-595 (2017).
5. Matsumura, Y. et al. Rapid Identification of Different Escherichia coli Sequence Type 131 Clades. Antimicrob Agents Chemother 61, e00179-17 (2017).
6. Matsumura, Y. et al. Global Escherichia coli Sequence Type 131 Clade with bla CTX-M-27 Gene. Emerg. Infect. Dis. 22, 1900–1907 (2016).
7. Matsumura, Y. et al. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis. 84, 322-327 (2016).
8. Matsumura, Y. et al. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H 30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. Journal of Antimicrobial Chemotherapy 70, 1639–1649 (2015).
9. Matsumura, Y. et al. Detection of Extended-Spectrum-β-Lactamase-Producing Escherichia coli ST131 and ST405 Clonal Groups by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry. J Clin Microbiol 52, 1034–1040 (2014).
10. Yamamoto, M. et al. Regional dissemination of Acinetobacter species harbouring metallo-β-lactamase genes in Japan. Clinical Microbiology and Infection 19, 729–736 (2013).
11. Yamamoto, M. et al. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans. Journal of Antimicrobial Chemotherapy 67, 2110–2113 (2012).
12. Matsumura, Y. et al. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan. International Journal of Antimicrobial Agents 40, 158–162 (2012).
13. Matsumura, Y. et al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. Journal of Antimicrobial Chemotherapy 67, 2612–2620 (2012).
14. Yamamoto, M. et al. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. Journal of Antimicrobial Chemotherapy 66, 2480–2483 (2011).